Novel MS Based Proteomics Technologies

Maarten Altelaar develops and implements novel MS based proteomics technologies to study protein regulation and cellular signaling processes. Emphasis lies on cancer signaling in acquired drug resistance and immunotherapy. High-throughput (phospho)proteomics complemented with targeted MS technologies are used to decipher proteome dynamics